-
Four departments issued a paper to end the Chinese medicine formula particle pilot
Time of Update: 2021-02-23
5. The provincial drug supervision and administration departments, together with the provincial Chinese medicine authorities, shall formulate corresponding management rules in the light of the relevant provisions of the national and local industrial policies and the actual clinical needs, adhere to the main position of Chinese medicine tablets, and ensure the smooth and orderly development and rational use of Chinese medicine formula particles within the jurisdiction.
-
Preparation export spring has not yet arrived in the transformation of API enterprises can not wait
Time of Update: 2021-02-06
At the opening ceremony of the exhibition, Zhou Hui, President of the China Medical and Health Products Import and Export Chamber of Commerce (the "Medical Insurance Chamber of Commerce"), stressed: "The pharmaceutical industry is one of the most promising industries in the world, and has maintained a relatively stable growth trend for many years." Today, the global pharmaceutical industry has undergone profound changes, and its supply chain and value chain layout are being reshaped.
-
The important pre-exam reminder for licensed pharmacists is here
Time of Update: 2020-06-17
The professional qualification examination of practicing pharmacists, from the origin and the latest changes June 4, the official website of the Chinese examination website published a message on the
-
NMPA approves Roche Pharmaceuticals Padter ® united with Herceptin ® and Dossie Tatse for treatment of metastatic breast cancer patients
Time of Update: 2020-06-07
recently, the Roche Pharmaceutical (http:// announced in China that The National Medicines (http:// Supervision Authority (NMPA) has officially approved the first-line standard treatment plan
